Irinotecan 100 mg/5 mL concentrate for infusion (Turkey) Irinotecan Targeted cancer therapy. Delivery from Europe within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.

Price for a 40 mg dosage - 2500 UAH

Indications

Treatment of patients with advanced colorectal cancer:

• In combination with 5-fluorouracil and folic acid in patients who have not received prior chemotherapy for the treatment of advanced disease;
• As monotherapy in patients for whom a treatment regimen using 5-fluorouracil has proven ineffective.
• In combination with cetuximab, Irinotecan "Ebewe" can be used to treat metastatic colorectal cancer with the wild-type KRAS gene expressing Epidermal growth factor receptor–negative patients who have not previously received treatment for metastatic cancer or for whom cytotoxic therapy with irinotecan has been ineffective.
• In combination with 5-fluorouracil, folic acid, and bevacizumab, Irinotecan "Ebewe" is used as first-line therapy in patients with metastatic colon or rectal carcinoma.
• In combination with capecitabine (with or without the addition of bevacizumab), Irinotecan "Ebewe" is used as first-line therapy in patients with metastatic colorectal cancer. 971772267;27